Mein Warenkorb

CD55

CD55 Molekülinformation

Englischer NameComplement decay-accelerating factorAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3Target-AliasDAF,Complement decay-accelerating factor,CD55,CD55 Molecule (Cromer Blood Group),CD55 Molecule, Decay Accelerating Factor For Complement (Cromer Blood Group),CD55 Antigen,CR,Decay Accelerating Factor For Complement (CD55, Cromer Blood Group System),Cromer Blood Group Antigen,CHAPLE,CROM,TC,CD55 Antigens
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameComplement decay-accelerating factor
Target-AliasDAF,Complement decay-accelerating factor,CD55,CD55 Molecule (Cromer Blood Group),CD55 Molecule, Decay Accelerating Factor For Complement (Cromer Blood Group),CD55 Antigen,CR,Decay Accelerating Factor For Complement (CD55, Cromer Blood Group System),Cromer Blood Group Antigen,CHAPLE,CROM,TC,CD55 Antigens
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

CD55 Produktliste

  • Attribut

    Protein (2)

  • Produktbibliothek

    Online (2)

  • Spezies

    Human (2)

  • Etikett

    His Tag (1)His Tag & Avi Tag (1)

  • Marker

    Unconjugated (1)Biotin-labeled (1)

ProduktnummerSpeziesExpressionssystemProduktbeschreibungProteinstrukturReinheitEigenschaftenVorbestellen/Bestellen
CD5-H5225
Human
HEK293
Human CD55 / DAF Protein, His Tag, low endotoxin
In den Warenkorb legen
CD5-H82E4
Human
HEK293
Biotinylated Human CD55 / DAF Protein, His,Avitag™ (MALS verified)
In den Warenkorb legen
Gesamtmenge2
  • 1

CD55 Molekülhintergrund

CD55 is also known as DAF or decay­accelerating factor, is a member of the RCA (regulators of complement activation) family characterized by four to 30 SCRs (short consensus repeats) in their plasma-exposed regions. CD55 /DAF is a 70 kDa membrane protein that regulates the complement system on the cell surface. It prevents the assembly of the C3bBb complex (the C3-convertase of the alternative pathway) or accelerates the disassembly of preformed convertase, thus blocking the formation of the membrane attack complex. This glycoprotein is broadly distributed among hematopoietic and non-hematopoietic cells. It is a determinant for the Cromer blood group system. CD55 is known to bind CD97 via the first SCR. It also binds physiologically­generated C3 convertases with its second and third SCRs. Binding results in an accelerated “decay”, or dissociation of active C3 convertases, thus blocking the development of C’ attack complexes on nonforeign cells. Finally, viruses and bacteria are also known to utilize multiple SCR sites for infection.

CD55 Molekülalias

CD55,DAF,CR,CROM,TC

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
GebasaxturevV-937; CVA-21Phase 2 ClinicalViralytics LtdBreast Neoplasms; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Prostatic Neoplasms; Urinary Bladder Neoplasms
Details
PAT-SC1SC-1; PAT-SC1; PAT-SC-1Phase 2 ClinicalOncomab GmbhStomach Neoplasms
Details
Recombinant coxsackievirus B3Phase 1 ClinicalWuhan Boweid Biotechnology Co LtdNeoplasms
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns